Unternehmens-Profil
Takeda Pharmaceutical Co., Ltd. is a leading global biopharmaceutical company headquartered in Japan. Its primary purpose is to discover, develop, and deliver innovative medicines that improve patients' lives, focusing on four main therapeutic areas: oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. Known for its strong research and development capabilities, Takeda drives advancements through both internal development efforts and strategic partnerships across the globe. As one of the largest pharmaceutical firms by revenue, Takeda plays a significant role in the healthcare industry, impacting patient care worldwide. The company's extensive global network enables it to serve patients in over 80 countries, underscoring its commitment to accessibility and impact in the pharmaceutical market.
Bewertungs-Kennzahlen
Allgemeine Finanzkennzahlen
Chart · 90 Tage
Letzter Kurs: 5 325 JPY· Stand 07.05.2026
News · Takeda Pharmaceutical Company Limited
- Takeda's immune disease drug meets main goal of mid-to-late stage trial
- Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)
- Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
- ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?
- Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?